Abstract PD9-04: Identification of biomarkers associated with therapeutic resistance: Quantitative protein/phosphoprotein analysis of ~750 patients across 8 arms of the neoadjuvant I-SPY 2 TRIAL for high-risk early stage breast cancer

Julia Wulfkuhle, Emanual Petricoin, Christina Yau et al.|Cancer Research|2021

Cited by 0